Evidence map›Paper›PMID 31330832›Full record

ArticleJournal of clinical medicine2019

Cost-Utility of Mindfulness-Based Stress Reduction for Fibromyalgia versus a Multicomponent Intervention and Usual Care: A 12-Month Randomized Controlled Trial (EUDAIMON Study).

Adrián Pérez-Aranda, Francesco D'Amico, Albert Feliu-Soler, Lance M McCracken, María T Peñarrubia-María, Laura Andrés-Rodríguez, Natalia Angarita-Osorio, Martin Knapp, Javier García-Campayo, Juan V Luciano

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review of Fibromyalgia (FM) Syndrome Treatments.International journal of environmental research and public health · 2022
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Adrián Pérez-ArandaGroup of Psychological Research in Fibromyalgia & Chronic Pain (AGORA), Institut de Recerca Sant Joan de Déu, 08950 Esplugues de Llobregat, Spain.
Francesco D'AmicoThe London School of Economics and Political Science (LSE), London WC2A 2AE, UK.
Albert Feliu-SolerGroup of Psychological Research in Fibromyalgia & Chronic Pain (AGORA), Institut de Recerca Sant Joan de Déu, 08950 Esplugues de Llobregat, Spain. a.feliu@pssjd.org.ORCID 0000-0003-2810-7670
Lance M McCrackenDepartment of Psychology, Uppsala University, SE-751 05 Uppsala, Sweden.
María T Peñarrubia-MaríaPrimary Health Centre Bartomeu Fabrés Anglada, SAP Delta Llobregat, Unitat Docent Costa de Ponent, Institut Català de la Salut, 08850 Gavà, Spain.
Laura Andrés-RodríguezGroup of Psychological Research in Fibromyalgia & Chronic Pain (AGORA), Institut de Recerca Sant Joan de Déu, 08950 Esplugues de Llobregat, Spain.
Natalia Angarita-OsorioGroup of Psychological Research in Fibromyalgia & Chronic Pain (AGORA), Institut de Recerca Sant Joan de Déu, 08950 Esplugues de Llobregat, Spain.
Martin KnappThe London School of Economics and Political Science (LSE), London WC2A 2AE, UK.
Javier García-CampayoPrimary Care Prevention and Health Promotion Research Network, RedIAPP, 28029 Madrid, Spain.
Juan V LucianoGroup of Psychological Research in Fibromyalgia & Chronic Pain (AGORA), Institut de Recerca Sant Joan de Déu, 08950 Esplugues de Llobregat, Spain. jvluciano@pssjd.org.ORCID 0000-0003-0750-1599
Red de Investigación en Actividades Preventivas y Promoción de la Salud · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESInstitut Universitari d'Investigació en Atenció Primària Jordi Gol · ESLondon School of Economics and Political Science · GBSant Joan de Déu Research Foundation · ESUppsala University · SE

Funding

MATRIX, HORMONES, AND DIFFERENTIATION IN MAMMALIAN CELLSK04CA000783 · NCI · YESHIVA UNIVERSITY · PI REID, LOLA M · 1985 to 1987
–
Agència de Gestió d'Ajuts Universitaris i de Recerca FI_B00754Agència de Gestió d'Ajuts Universitaris i de Recerca FI_B00783Instituto de Salud Carlos III CD16/00147Instituto de Salud Carlos III CP14/00087Instituto de Salud Carlos III RD16/0007/0005Instituto de Salud Carlos III RD16/0007/0012
6 · The paper itself

Abstract

Fibromyalgia (FM) is a prevalent, chronic, disabling, pain syndrome that implies high healthcare costs. Economic evaluations of potentially effective treatments for FM are needed. The aim of this study was to analyze the cost-utility of Mindfulness-Based Stress Reduction (MBSR) as an add-on to treatment-as-usual (TAU) for patients with FM compared to an adjuvant multicomponent intervention ("FibroQoL") and to TAU. We performed an economic evaluation alongside a 12 month, randomized, controlled trial; data from 204 (68 per study arm) of the 225 patients (90.1%) were included in the cost-utility analyses, which were conducted both under the government and the public healthcare system perspectives. The main outcome measures were the EuroQol (EQ-5D-5L) for assessing Quality-Adjusted Life Years (QALYs) and improvements in health-related quality of life, and the Client Service Receipt Inventory (CSRI) for estimating direct and indirect costs. Incremental cost-effectiveness ratios (ICERs) were also calculated. Two sensitivity analyses (intention-to-treat, ITT, and per protocol, PPA) were conducted. The results indicated that MBSR achieved a significant reduction in costs compared to the other study arms (

Indexed as

cost-effectivenesscost–utilityfibromyalgiaquality-adjusted life years

Identifiers

PMID31330832
PMCPMC6678679
OpenAlexW2963244528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.